Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Jan;31(1):93–99. doi: 10.1128/aac.31.1.93

Silver-coated nylon fiber as an antibacterial agent.

P C MacKeen, S Person, S C Warner, W Snipes, S E Stevens Jr
PMCID: PMC174659  PMID: 3105444

Abstract

A blend of nylon fiber and silver-coated nylon fiber (the latter known as X-static) was used in these experiments. This fiber was bactericidal when bacteria were exposed to it directly or to an extract derived from its prior incubation in salt solution. At ambient temperatures, a rapid exponential decrease of survival occurred, usually after a delay of approximately 1 h. The rate of killing (decrease of survival) increased with an increase in X-static percentage of the fiber blend, temperature of fiber extraction, concentration of Tris buffer present during extraction, and temperature at which bacteria were exposed to the extract. When bacteria were exposed to the extract at 37 degrees C as opposed to ambient temperature, there was no delay in onset of killing. Escherichia coli was generally the indicator organism tested, but comparable results were also found for Pseudomonas, Klebsiella, Staphylococcus, and Streptococcus species. The rate of killing increased with increasing silver ion concentration of the fiber extract, as determined through atomic absorption spectrophotometry. The rate of killing was greater and the onset was earlier with an extract containing silver ions from fiber than with a salt solution containing the same concentration of silver ions from silver nitrate. Studies of the kinetics of ion release suggested that X-static may be an effective, sustained-release antibacterial agent.

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger T. J., Spadaro J. A., Chapin S. E., Becker R. O. Electrically generated silver ions: quantitative effects on bacterial and mammalian cells. Antimicrob Agents Chemother. 1976 Feb;9(2):357–358. doi: 10.1128/aac.9.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Deitch E. A., Marino A. A., Gillespie T. E., Albright J. A. Silver-nylon: a new antimicrobial agent. Antimicrob Agents Chemother. 1983 Mar;23(3):356–359. doi: 10.1128/aac.23.3.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fox C. L., Jr, Modak S. M. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother. 1974 Jun;5(6):582–588. doi: 10.1128/aac.5.6.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fox C. L., Jr Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg. 1968 Feb;96(2):184–188. doi: 10.1001/archsurg.1968.01330200022004. [DOI] [PubMed] [Google Scholar]
  5. Fox C. L., Jr Topical therapy and the development of silver sulfadiazine. Surg Gynecol Obstet. 1983 Jul;157(1):82–88. [PubMed] [Google Scholar]
  6. Hoffmann S. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature. Scand J Plast Reconstr Surg. 1984;18(1):119–126. doi: 10.3109/02844318409057413. [DOI] [PubMed] [Google Scholar]
  7. Modak S. M., Fox C. L., Jr Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol. 1973 Oct 1;22(19):2391–2404. doi: 10.1016/0006-2952(73)90341-9. [DOI] [PubMed] [Google Scholar]
  8. Nathan P., Robb E. C., Law E. J., MacMillan B. G. A clinical study of antimicrobial agents delivered to burn wounds from a drug-loaded synthetic dressing. J Trauma. 1982 Dec;22(12):1015–1018. doi: 10.1097/00005373-198212000-00006. [DOI] [PubMed] [Google Scholar]
  9. Osborn M., Person S. Characterization of revertants of E. coli WU36-10 and WP2 using amber mutants and an ochre mutant of bacteriphage T4. Mutat Res. 1967 Jul-Aug;4(4):504–507. doi: 10.1016/0027-5107(67)90013-9. [DOI] [PubMed] [Google Scholar]
  10. Robb E. C., Fitz D. G., Nathan P. Delivery of the topical antimicrobial agents silver sulfadiazine, gentamicin and nystatin to infected burn wounds in rats from preloaded synthetic dressings. Trans Am Soc Artif Intern Organs. 1980;26:533–536. [PubMed] [Google Scholar]
  11. Robb E. C., Nathan P. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing. J Trauma. 1981 Oct;21(10):889–893. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES